Please don't be a lurker and join us at X-Factor
Welcome Guest [Log In] [Register]
Welcome to Xfactor. We hope you enjoy your visit.


You're currently viewing our forum as a guest. This means you are limited to certain areas of the board and there are some features you can't use. If you join our community, you'll be able to access member-only sections, and use many member-only features such as customizing your profile, sending personal messages, and voting in polls. Registration is simple, fast, and completely free.

Please Bookmark this site so you dont forget the URL and dont forget please advertise us in your webspace
Join our community!


If you're already a member please log in to your account to access all of our features:

Username:   Password:
Add Reply
Celgene Corp announces Postive note
Topic Started: Dec 15 2009, 03:52 PM (80 Views)
.:STONE:.
Member Avatar
Administrator

Posted Image
Celgene Corp (CELG.O) said on Tuesday its experimental drug to treat the skin condition psoriasis reduced symptoms by a significant amount in a mid-stage trial.

Results of the 352-patient trial showed that 41 percent of patients treated with 30 milligrams of the drug, apremilast, twice a day, saw a 75 percent reduction in symptoms as measured by a score known as the Psoriasis Area and Severity Index (PASI-75) after 16 weeks.

Only 6 percent of patients receiving a placebo achieved that score.

Celgene's shares fell 0.87 percent in mid-morning trading to $53.41, in line with a 0.71 percent decline in the NYSE Arc Biotech Index .BTK

Read More Here
*****BOARD ADMINISTRATOR*****
Offline Profile Quote Post Goto Top
 
1 user reading this topic (1 Guest and 0 Anonymous)
« Previous Topic · Portal News · Next Topic »
Add Reply

Dont Hesitate to contact the administrator should you have some Queries